Lek to build US$400 million production facility in Lendava

Lek, the Ljubljana-based pharmaceutical company which is part of the Swiss generics group Sandoz, will build a US$400 million high-tech production centre for biosimilars in Lendava, in north-eastern Slovenia. The investment is to create around 300 new jobs.

The memorandum of understanding on the investment was signed on 9 March by Robert Ljoljo, CEO of Lek and Sandoz Slovenia president, and Minister of the Economy, Tourism and Sport Han.

Prime Minister Robert Golob, who was present at the signing, said the government would support the €379 million investment with an incentive...